I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule - Report - MDSpire

I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule

  • By

  • David J. Skorton

  • June 12, 2026

  • 0 min

Share

Threats to American Scientific Research: Proposed Grantmaking Regulations

Overview

The proposed revisions to federal grantmaking regulations threaten the integrity of scientific research by introducing political biases into the funding process. This could undermine decades of progress in American science and innovation, which has historically thrived under a system of peer review and scientific judgment.

Background

The American research enterprise has been pivotal in advancing medical science, leading to significant breakthroughs in treatments for diseases like childhood leukemia and innovations in technology. However, recent proposed changes to grantmaking regulations may jeopardize this progress by intertwining political agendas with scientific funding decisions. Maintaining the independence of scientific inquiry is crucial for continued advancements in health and technology.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • The proposed rule would require research grants to align with the President's policy priorities.
  • Historically, scientific research has thrived under a system of peer review, free from political influence.
  • Federal funding for research has significant economic returns, with every dollar of NIH funding generating $2.57 in new economic activity.
  • Politicizing research funding could deter scientists and undermine America's global leadership in scientific innovation.
  • Uncertainty in federal funding has already led to challenges for researchers in securing grants.

Clinical Implications

Healthcare professionals should be aware of the potential impacts of political influences on research funding, which may affect the development of new treatments and therapies. Advocacy for maintaining the integrity of the scientific review process is essential to ensure continued progress in medical research.

Conclusion

The proposed changes to grantmaking regulations pose a significant risk to the future of American scientific research. Preserving the independence of scientific inquiry is vital for fostering innovation and improving patient care.

Related Resources & Content

  1. Stat News, 2026 -- Securing NIH awards is getting more competitive — and confusing
  2. the analytical scientist, 2026 -- Federal Funding Uncertainty Leaves US Research in Limbo
  3. The New Gastroenterologist, 2025 -- A Challenge to Advancements in Scientific Research
  4. The ASCO Post, 2013 -- The Scientific Perils of Sequestration
  5. Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children | New England Journal of Medicine
  6. Survival Improves With Perioperative Pembrolizumab in Early-Stage NSCLC | CancerNetwork
  7. FDA - CASGEVY
  8. Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children | New England Journal of Medicine
  9. Survival Improves With Perioperative Pembrolizumab in Early-Stage NSCLC | CancerNetwork

Original Source(s)

Related Content